American Well Corporation

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AMWL reports Q4 achievements, eyes revenue growth through Converge

AMWL's Q4 performance highlighted achievements in client migrations and strategic partnerships, with a focus on revenue growth for 2023.
Strengths include ACV growth, strong demand for behavioral health solutions, and the potential of the Converge platform to drive integration.
Challenges lie in revenue outlook impacted by customer churn, while opportunities exist in driving growth through Converge and service revenue.
Despite uncertainties, AMWL remains confident in its position in the digital care market and readiness to capitalize on market opportunities.

American Well (AMWL) reports Q1 growth amid margin challenges

AMWL's Q1 performance showed revenue growth but challenges in margins due to operational factors.
The company's focus on customer relationships and solution-based sales strategy are key strengths.
Opportunities lie in leveraging subscription revenue, market receptivity, and a strong financial position for future growth.
Challenges include margin pressures, limited growth avenues without mergers, and market scrutiny on key operational metrics.

American Well (AMWL) excels in Q2 with Converge migrations and international partnerships

AMWL's Q2 performance showcased strong client migrations, new wins, and international partnerships, with a focus on profitability.
Converge's modularity and end-to-end experience drive efficiency and positive renewals, while challenges include managing churn and pricing.
Opportunities in successful client migrations, market shift towards production platforms, and behavioral health integration are key growth areas.
Efforts to simplify the customer journey and accelerate ROI realization through modular approaches are underway for AMWL.

AMWL excels in Q3 with government wins and strategic partnerships

American Well Corporation's Q3 earnings call highlighted strong performance, strategic wins, and operational improvements positioning the company for future growth.
While facing challenges with legacy platforms, AMWL's focus on Converge, cost savings, and client engagement presents opportunities for enhanced profitability.
With a clear roadmap for growth and a focus on customer-centric solutions, AMWL is poised for significant revenue expansion and margin improvement in the coming years.

AMWL reports solid Q4 performance, eyes revenue growth opportunities

AMWL's Q4 performance reflects strategic advancements, high client satisfaction, and revenue diversification, positioning the company for future growth.
While facing challenges in achieving breakeven EBITDA and addressing subscription revenue declines, AMWL's strengths in market traction and sales model transformation offer growth opportunities.
Guidance for 2024 and 2025 outlines a clear path towards revenue growth, improved EBITDA, and leveraging Converge for enhanced customer value and revenue generation.

American Well (AMWL) reports strong Q1 growth and eyes retail expansion

American Well's Q1 performance showcased growth and cost structure improvements, with a focus on subscription revenue.
The company's strategic initiatives target efficiency improvements and higher-margin software subscriptions.
Opportunities lie in market shifts towards complete healthcare solutions and expansion with existing customers.
Challenges include cost initiatives towards profitability and addressing impacts of lower subscription software revenue.

American Well Corp. reports revenue growth and boosts EBITDA guidance

AMWL's Q2 2024 performance reflects positive revenue growth, improved gross profit margin, and adjusted EBITDA guidance raise, underlining the company's progress.
While facing challenges in achieving positive EBITDA and operational efficiency, AMWL's strengths in customer relationships, cost-cutting measures, and market positioning offer strategic advantages.
Opportunities for AMWL include optimizing spend, expanding client base, and leveraging its unique position in the digital healthcare market to drive future growth and profitability.

American Well Corp reports Q3 growth and strategic positioning

American Well Corporation (AMWL) demonstrated steady revenue growth and a commitment to strategic initiatives in Q3 2024.
While facing challenges in achieving profitability, the company's focus on cost alignment and growth positioning bodes well for future performance.
Opportunities in leveraging key contracts and subscription revenue growth position AMWL for continued success in the healthcare technology sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The stock has doubled since its hot IPO, but coronavirus-induced trends might not be enough to satisfy investors seeking outsized gains.

Is Amwell Stock a Buy?

Casper Sleep

Shift4 Payments

Social Capital Hedosophia Holdings Corp. II 

Snowflake

Vroom

XPeng

Recent IPOs have included some of the bigger winners of the past few years. But these seven stocks could hit trouble soon after going public.

7 Red-Hot Recent IPOs to Ditch Now

Alibaba

GameStop

InflaRx

Sony

Smith & Wesson Brands

VBI Vaccines

It wasn't just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.

7 Short-Term Stocks to Make a Quick Buck

Albertsons Companies

Dollar General

Gilead Sciences

Home Depot

NIKE

Sociedad Quimica Y Minera De Chile

Wheaton Precious Metals

With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.

9 Stocks to Buy for a Wild Ride in October

Teladoc

It accuses its rival of nine violations related to two products.

Teladoc Is Suing Amwell for Patent Infringement

After its IPO, telemedicine play American Well stock has been hot. Ignore the takeover rumors and wait to buy AMWL on any pullback.

Recent IPO American Well Stock Is a Buy on Any Pullback

With telehealth gaining a substantial foothold during the novel coronavirus pandemic, it’s no surprise that American Well stock has outperformed since its IPO. But beyond this crisis, AMWL has a strong bullish narrative.

The New Normal Is the Real Catalyst for American Well Stock

Several analysts are giving the stock an enthusiastic thumbs-up.

Why American Well Was a Big Winner on Monday

Like many tech companies, AMWL has grown at an exponential rate while remaining unprofitable. Is there a path to profitability? Sure.

Has AMWELL gone too high too fast?

Access to healthcare in America has changed, and these two companies could help you benefit.

The Top 2 Telehealth Stocks to Buy in October

UnitedHealth Group

Recently listed shares of the telehealth start-up recently jumped in response to speculation that America's largest health insurer was considering an acquisition.

Should UnitedHealth Acquire Amwell?

BOSTON, Oct. 9, 2020 /PRNewswire/ -- Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced the appointment of Ms. Deborah C. Jackson to the Company's Board of Directors, effective immediately. "We are thrilled to welcome Deborah to our Board of Directors,"...

Amwell Announces Appointment of Deborah C. Jackson to its Board of Directors

AmWell is riding high after its IPO last month. Can it keep the momentum going?

Is This Sizzling IPO Stock Getting Too Hot to Handle?

Anthem

CVS Health

GoodRx Holdings

Humana

Livongo Health Inc

Remote and virtual medicine has taken off during the pandemic, and these telehealth stocks -- and their investors -- are reaping the rewards. The post 7 Telehealth Stocks Paving the Digital Medicine Landscape appeared first on InvestorPlace.

7 Telehealth Stocks Paving the Digital Medicine Landscape

It helps that the company operates in the white-hot telehealth segment.

Why Amwell Blasted Higher on Wednesday

Amwell,a telehealth company that went public recently, is now valued at about $6.5 billion, or about $28 per share, implying 55% gains from its IPO price of $18 a share. The company trades at 18x trailing Revenues largely in-line with some other telehealth companies.

What’s Next For Amwell After 55% Growth From IPO Price?

The recent IPO for American Well Corporation included $100M in capital from Google, providing a tech partner to capitalize on the seismic shifts taking place in the healthcare delivery system.

American Well Corporation: Turning Pandemic Tailwinds Into Sustainable Revenue Growth

Telehealth stocks are in limelight as the coronavirus pandemic accelerates adoption of telehealth services. Robust industry growth likely in the coming years.

3 Telehealth Stocks Ready for Flu Season

Which Hot IPO Stock Is More Likely to Make You Rich: Amwell or GoodRx?

Exact Sciences

Owens & Minor

Find out what drove these stocks higher to see if they can do it again.

3 Healthcare Stocks That Jumped Higher Last Week

Forum Merger II

Nikola

Here are new stocks to buy among IPOs and SPACs that have the potential to be creators of long-term value.
The post 4 New Stocks That Can Be Long-Term Value Creators appeared first on InvestorPlace.

4 New Stocks That Can Be Long-Term Value Creators

Remote healthcare has been a top investment theme for 2020, and Amwell aims to capitalize on the trend.

Is Google-Backed Telemedicine Stock Amwell a Buy After Its IPO?

Amwell and Teladoc have a lot in common, but their differences matter most.

Is This Hot IPO Stock a Better Buy Than Teladoc Health?

One of the stock market's newest arrivals issues a pair of encouraging updates.

Why Shares of American Well Trounced the Market on Tuesday

BOSTON, Sept. 21, 2020 /PRNewswire/ -- Amwell®, a national telehealth leader, today announced the closing of its upsized initial public offering of 47,405,555 shares of its Class A common stock at an initial offering price of $18.00 per share, which includes the full exercise of the underwriters' option to purchase 6,183,333 additional shares of Class A common stock from Amwell and certain stockholders of Amwell (the "Selling Stockholders").

News for American Well Corporation Stock (AMWL)